Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
January 02 2020 - 4:01PM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a
corporate update at the 38th Annual J.P. Morgan Healthcare
Conference on Monday, January 13, 2020 at 4:00 p.m. Pacific Time/
7:00 p.m. Eastern Time at the Westin St. Francis Hotel in San
Francisco. The presentation will be followed by a question and
answer session that will begin at 4:30 p.m. Pacific Time/ 7:30 p.m.
Eastern Time.
A live webcast of Ironwood’s presentation and the question and
answer session will be accessible through the Investors section of
the company’s website at www.ironwoodpharma.com. To access the
webcast, please log on to the Ironwood website approximately 15
minutes prior to the start time to ensure adequate time for any
software downloads that may be required. A replay of the webcast
will be available on Ironwood’s website for 14 days following the
conference.
About Ironwood Pharmaceuticals Ironwood Pharmaceuticals
(Nasdaq: IRWD) is a GI-focused healthcare company dedicated to
creating medicines that make a difference for patients living with
GI diseases. We discovered, developed and are commercializing
linaclotide, the U.S. prescription market leader for adults with
irritable bowel syndrome with constipation (IBS-C) or chronic
idiopathic constipation (CIC).
We are also advancing two late-stage, first-in-category GI
product candidates: IW-3718 is a gastric retentive formulation of a
bile acid sequestrant being developed for the potential treatment
of persistent gastroesophageal reflux disease, and MD-7246 is a
delayed-release formulation of linaclotide that is being evaluated
as an oral, intestinal, non-opioid, pain-relieving agent for
patients suffering from abdominal pain associated with IBS with
diarrhea.
Ironwood was founded in 1998 and is headquartered in Boston,
Mass. For more information, please visit our website at
www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200102005489/en/
Media and Investors: Meredith Kaya, 617-374-5082 Vice
President, Strategy, Investor Relations and Corporate
Communications mkaya@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jul 2023 to Jul 2024